Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
This is probably a good time to remind ourselves of the time 23AndMe genetic data got hacked and most likely sold on the dark web. This data is all over the place at this point, and it affects not just the individuals who took the tests but also their relatives.
data protection is at risk of becoming an oxymoron